Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04798547 · ClinicalTrials.gov registry record · NA

Short Vs Standard Length Myotomy in Achalasia

A NA study of Achalasia, sponsored by Northwestern University.

Completed
Registry status
NA
Development phase
60
Enrollment target
1
Study location

NCT04798547 is a NA study of Achalasia that has completed, run by Northwestern University. The registered enrollment target is 60 participants, below the 133-participant average among 7 other Achalasia trials with a reported enrollment target (55% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04798547, a NA study of Achalasia, has completed, sponsored by Northwestern University.

COMPLETED
Registry status
NA
Development phase
60 participants
Enrollment target
1
Study location

Study Summary

The objective of this randomized controlled trial (non-inferiority study) is to evaluate the outcomes of 4 cm short myotomy compared to the 8 cm standard length myotomy in Per-Oral Endoscopic Myotomy (POEM) for patients with achalasia. We hypothesize that a shorter myotomy with POEM will have the same clinical efficacy as standard length myotomy based on patient-reported Eckardt score with shorter procedure times and reduced complications.

Conditions Studied

Interventions

  • PROCEDURE Short Myotomy
  • PROCEDURE Standard Length Myotomy

Study Locations (1)

Illinois

  • Northwestern Memorial Hospital - Chicago

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2020-06-01
Est. Completion 2024-02-29
Phase NA

Sponsor

Northwestern University

1,209 total trials

What the Registry Record Tells You About NCT04798547

The ClinicalTrials.gov registry entry for NCT04798547 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 133-participant average among 7 other Achalasia trials with a reported enrollment target (55% lower). The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Achalasia appearing as the primary indexed condition, and to 2 interventions - of which Short Myotomy is the first listed.

NCT04798547 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.

Frequently Asked Questions

What is clinical trial NCT04798547 about?

NCT04798547 is a clinical study titled "Short Vs Standard Length Myotomy in Achalasia". The objective of this randomized controlled trial (non-inferiority study) is to evaluate the outcomes of 4 cm short myotomy compared to the 8 cm standard length myotomy in Per-Oral Endoscopic Myotomy (POEM) for patients with achalasia. We hypothesize that a shorter myotomy with POEM will have the sa...

What is the current status of trial NCT04798547?

This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2020-06-01. Estimated completion is 2024-02-29.

What conditions does trial NCT04798547 study?

This clinical trial studies the following conditions: Achalasia.

What interventions are being tested in trial NCT04798547?

The interventions under investigation include: Short Myotomy (PROCEDURE), Standard Length Myotomy (PROCEDURE).

Who is sponsoring clinical trial NCT04798547?

This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04798547 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Achalasia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.